Table III.
Features | n (%) |
---|---|
Mass-like enhancement | 4 |
Shape | |
Oval | 1 (25) |
Irregular shape | 3 (75) |
Edge | |
Clear | 1 (25) |
Irregular | 2 (50) |
Burr | 1 (25) |
Internal enhancement feature | |
Uniform | 1 (25) |
Inhomogeneous | 2 (50) |
Edge enhancement | 1 (25) |
Non-mass enhancement | 4 |
Distribution | |
Linear | 1 (25) |
Focal | 2 (50) |
Regional | 1 (25) |
Internal enhancement feature | |
Uniform | 2 (50) |
Inhomogeneous | 1 (25) |
Cluster-like | 1 (25) |
TIC | 8 |
Early stage | |
Slow | 1 (12.5) |
Medium | 1 (12.5) |
Fast | 6 (75) |
Delay stage | |
Outflow type | 8 (100) |
Axillary lymph node metastasis | 6 |
(+) on MRI | 3 (50) |
(−) on MRI | 3 (50) |
Metastatic lymph nodes detected by MRI | 8 |
Sensitivity | 50% |
Specificity | 100% |
Positive predictive value | 100% |
Negative predictive value | 40% |
Overall accuracy | 62.5% |
Invasion of the nipple, chest wall or skin | 2 (25) |
MRI, magnetic resonance imaging; IMPC, invasive micropapillary carcinoma; TIC, time-intensity curve.